Back to Trades
Trieu Vuong
CHAIRMAN AND CEODirector10% OwnerCIK 0001587074
Profile
- Filings
- 8
- Buy transactions
- 11
- Sell transactions
- 0
- Companies
- 1
- Active
- 2025–2026
Trieu Vuong, CHAIRMAN AND CEO, Director, 10% Owner, has filed 8 SEC reports (2025–2026), all concentrated in Oncotelic Therapeutics, Inc. (OTLC), totaling $61.4K in disclosed volume. Weighing $61.4K bought versus $0 sold, the history is heavily weighted toward buying. The largest single open-market purchase on record is $23.5K in Oncotelic Therapeutics, Inc.. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
8 loaded
| Oct 30 | OTLC Oncotelic Therapeutics, Inc. | Trieu Vuong | CHAIRMAN AND CEO, Director, 10% Owner | Buy | $23.5K |
| Jul 14 | OTLC Oncotelic Therapeutics, Inc. | Trieu Vuong | CHAIRMAN AND CEO, Director, 10% Owner | Award | $0 |
| Jul 2 | OTLC Oncotelic Therapeutics, Inc. | Trieu Vuong | CHAIRMAN AND CEO, Director, 10% Owner | Buy | $10.3K |
| Jun 24 | OTLC Oncotelic Therapeutics, Inc. | Trieu Vuong | CHAIRMAN AND CEO, Director, 10% Owner | Buy | $11.5K |
| Jun 17 | OTLC Oncotelic Therapeutics, Inc. | Trieu Vuong | CHAIRMAN AND CEO, Director, 10% Owner | Buy | $15.0K |
| Jan 26 | OTLC Oncotelic Therapeutics, Inc. | Trieu Vuong | CHAIRMAN AND CEO, Director, 10% Owner | Award | $0 |
| Nov 19 | OTLC Oncotelic Therapeutics, Inc. | Trieu Vuong | CHAIRMAN AND CEO, Director, 10% Owner | Award | $0 |
| Jul 10 | OTLC Oncotelic Therapeutics, Inc. | Trieu Vuong | CHAIRMAN AND CEO, Director, 10% Owner | Buy | $994 |
8 filings